Home/Filings/4/0000950172-24-000233
4//SEC Filing

Glickman Richard M 4

Accession 0000950172-24-000233

CIK 0001633932other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 10:35 AM ET

Size

6.2 KB

Accession

0000950172-24-000233

Insider Transaction Report

Form 4
Period: 2024-04-24
Transactions
  • Exercise/Conversion

    Common Shares

    2024-04-24$4.90/sh+3,750$18,37543,240 total
  • Exercise/Conversion

    Options

    2024-04-243,7500 total
    Exercise: $4.90From: 2022-03-21Exp: 2024-05-21Common Shares (3,750 underlying)

Documents

1 file

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1
  • filerCIK 0001352637

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 10:35 AM ET
Size
6.2 KB